RecruitingNot ApplicableNCT06799832

Urethral PeRfusion Index-Guided Hemodynamic ManagemenT in Patients Having Major Abdominal Surgery: the UPRIGHT Randomized Feasibility Trial


Sponsor

Universitätsklinikum Hamburg-Eppendorf

Enrollment

116 participants

Start Date

Jan 21, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

We will perform this single-center pilot trial to determine if the intraoperative urethral perfusion index is higher in patients assigned to maintaining postinduction baseline urethral perfusion index than in patients assigned to routine care (with blinded urethral perfusion index monitoring). As pre-planned substudies, we will also assess the agreement between a) urethral perfusion index-derived pulse rate and heart rate measured with an electrocardiogram and b) between the urethral perfusion index and the peripheral perfusion index.


Eligibility

Min Age: 45 Years

Inclusion Criteria4

  • at least 45 years old
  • scheduled for elective major abdominal surgery (involving visceral organs with an expected duration of at least 120 minutes)
  • indication for an arterial catheter
  • indication for an urinary catheter

Exclusion Criteria4

  • Pregnancy
  • Planned surgery: nephrectomy, liver or kidney transplantation surgery
  • Patients who previously had surgery on the urethra or bladder
  • Patients without clinical indication for continuous blood pressure monitoring with an intraarterial catheter

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEurethal perfusion index monitoring

The urethral perfusion index will be monitored using the IKORUS System (Vygon, Écouen, France)


Locations(2)

University Medical Center Hamburg-Eppendorf

Hamburg, Germany

University Medical Center Hamburg-Eppendorf

Hamburg, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06799832